SPR Therapeutics, LLC

Cleveland, OH 44122

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $7.11MM
First Award Date 05/01/14
Most Recent Award Date 07/15/17

Key Personnel

Last Name Name Awards Contact
BENNETT MARIA BENNETT 2
BOGGS JOSEPH WILDER BOGGS 6

8 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 07/15/17 - 05/31/18

? DESCRIPTION (provided by applicant): The goal of this project is to evaluate the feasibility (Phase I) and demonstrate the safety and effectiveness (Phase II) of a novel peripheral nerve stimulation therapy to treat pain and enable early rehabilitation after total knee arthroplasty (i.., replacement), resulting in improved function, indepen...

Phase SBIR

Agency: Department of Health & Human Services
Topic: PAR-16-027
Budget: 03/15/17 - 02/28/18

Abstract: The goal of the presently proposed Commercialization Readiness Pilot (CRP) Program project is to prepare for commercialization of an implantable system (developed in Phase II) that is capable of delivering a novel peripheral nerve stimulation (PNS) therapy shown to be highly effective in treating intractable pain in a majority of amput...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 06/01/16 - 05/31/17

? DESCRIPTION (provided by applicant): The goal of this project is to evaluate the feasibility (Phase I) and demonstrate the safety and effectiveness (Phase II) of a novel peripheral nerve stimulation therapy to treat pain and enable early rehabilitation after total knee arthroplasty (i.., replacement), resulting in improved function, independ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/01/16 - 02/28/17

DESCRIPTION (provided by applicant): The long term goal of this research is to commercialize a neurostimulation system to treat post- amputation pain. Approximately 1.8 million individuals in the U.S. are living with an amputation, and about 185,000 individuals undergo an amputation each year. Post-amputation pain has a high incidence (95%) and ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 08/15/15 - 01/31/16

DESCRIPTION (provided by applicant): The goal of this project is to evaluate the feasibility (Phase I) and demonstrate the safety and effectiveness (Phase II) of a novel peripheral nerve stimulation therapy to treat pain and enable early rehabilitation after total knee arthroplasty (i.., replacement), resulting in improved function, independence...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 05/01/15 - 03/31/16

DESCRIPTION (provided by applicant): The goal of this project is to collect the safety and effectiveness clinical data necessary to commercialize the SMARTPATCH(R) system for post-stroke shoulder pain (PSSP). The prevalence of stroke is approximately 8 million in the US, with 795,000 additional persons surviving a stroke each year. Moderate to ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/01/15 - 02/29/16

DESCRIPTION (provided by applicant): The long term goal of this research is to commercialize a neurostimulation system to treat post- amputation pain. Approximately 1.8 million individuals in the U.S. are living with an amputation, and about 185,000 individuals undergo an amputation each year. Post-amputation pain has a high incidence (95%) and ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 05/01/14 - 04/30/15

DESCRIPTION (provided by applicant): The goal of this project is to collect the safety and effectiveness clinical data necessary to commercialize the SMARTPATCH(R) system for post-stroke shoulder pain (PSSP). The prevalence of stroke is approximately 8 million in the US, with 795,000 additional persons surviving a stroke each year. Moderate to ...